Publication details
Antikoagulační léčba u srdečního selhání a hypertenze
| Title in English | Anticoagulation in heart failure and hypertension |
|---|---|
| Authors | |
| Year of publication | 2016 |
| Type | Article in Proceedings |
| Conference | Arteriální hypertenze - současné klinické trendy XIV |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | heart failure; hypertension; atrial fibrilation; warfarine; dabigatran; rivaroxaban; apixaban; edoxaban; idaricizumab; adnexanet alfa |
| Description | Pharmacological treatment of atrial fibrillation in the context of heart failure and hypertension poses numerous challenges. This review proposes a structured action plan for managing atrial fibrillation coexisting with heart failure that considers published clinical guidelines and integrates recent data derived from substudies of randomized trials, including the atrial fibrillation and congestive heart failure and hypertension trials. |